Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by Lemoyneon Oct 17, 2023 10:49pm
200 Views
Post# 35688311

Boys and girls, go check US tlry SEC filings

Boys and girls, go check US tlry SEC filings
LABS was issued 1.37M shares on sept 29th and 202k shares on oct 13th.

For each of those filings, the number of tlry shares currently owned by LABS was disclosed.

When they disclosed the second batch of 202k shares on oct 13th, the number of shares currently owned by LABS was 202k.

And so, LABS sold the first batch of 1.37M shares in between sept29 and oct 12th. We do not know the avg share sale price.

Why would LABS sell? Because tlry share price is doomed as they have a ton of debt coming at them and they will most probably dilute their shareholders into oblivion.
<< Previous
Bullboard Posts
Next >>